Antonella Brunello

Has grant

Istituto Oncologico Veneto IOV-IRCCS

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

RANDOMIZED PHASE II TRIAL OF METRONOMIC CYCLOPHOSPHAMIDE vs DOXORUBICIN IN ELDERLY PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS: THE METROPHOLYS TRIAL

Open Date: 2016-01-01

Close Date:

Grant: Close

VALIDATION OF MPI AS PROGNOSTIC INDEX FOR ELDERLY CANCER PATIENTS; EVALUATION OF COMORBIDITY, POLIPHARMACOLOGY AND POTENTIAL DRUG INTERACTIONS; PAIN ASSESSMENT AND TREATMENT AND CORRELATION WITH QUALITY OF LIFE IN ELDERLY (AGE > 70 YEARS) PATIENTS WITH CANCER

Open Date: 2011-01-01

Close Date: 2013-01-01

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (16)

Vittorio Lorenzo Quagliuolo

Chief

IRCCS Humanitas Research Hospital

ITALY

Antonella Brunello

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (19)

Beyond Treatment Decisions: The Predictive Value of Comprehensive Geriatric Assessment in Older Cancer Patients

Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)

What do cancer patients experience of the simultaneous care clinic? Results of a cross‐sectional study on patient care satisfaction

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)

Antigen rapid diagnostic test monitoring for SARS‐CoV‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?

Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting

Desmoid Tumors in the Active Surveillance Era: Evaluation of Treatment Options and Pain Relief in a Single-Center Retrospective Analysis

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain

Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study

Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy

Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer Center

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group

Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian rare cancer network

Older cancer patients and COVID‐19 outbreak: Practical considerations and recommendations

Caring for Patients with Advanced Stage Cancer at the Time of COVID ‐19

Collaborators (16)

Vittorio Lorenzo Quagliuolo

Roberta Sanfilippo

Sandro Pasquali

Anna Belloni Fortina

Javier Martín-Broto

Emanuela Palmerini

Luigi Mariani

alberto righi

Umberto Basso

stefano piaserico

Irene Quattrini

mario caccese

Marco Gambarotti

Paolo Del Fiore

Gian Paolo Dagrada

Elisa Carretta

Make your next move.